Johnson & Johnson has been hit with a new crop of suits in federal court in Newark claiming its blockbuster drug Levaquin caused users to suffer nerve damage.

Between Aug. 1 and 11, the firm of Bernstein Liebhard has filed 13 Levaquin suits with 18 plaintiffs in the District of New Jersey against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]